Oncology studies present unique challenges when it comes to participant treatment, resupply, and study management.
Lab test overhaul: FDA to regulate LDTs as medical devices
The Food and Drug Administration’s final rule solidifying its authority over laboratory developed tests (LDTs) marks a major shift in the regulation of the diagnostics